List of insiders holdings for DiaMedica Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Von Koch Thomas TomEnterprise AB TomEnterprise Private AB 10% Owner |
2024-07-01 16:27:16 | 0 5,526,435 |
5,526,435 | Form 4 |
| 2 | STAHLBERG JAN TRILL AB 10% Owner |
2024-07-01 16:24:38 | 0 5,221,608 |
5,221,608 | Form 4 |
| 3 | JACINTO RICHARD II 10% Owner |
2023-06-23 17:13:56 | 4,558,823 0 |
4,558,823 | Form 13G |
| 4 | Xiao Zhenyu Hermeda Industrial Co. Ltd Director 10% Owner |
2020-12-23 16:31:17 | 936,805 0 |
936,805 | Form 13G |
| 5 | Xiao Zhenyu Director |
2020-12-23 16:31:17 | 936,805 0 |
936,805 | Form 13G |
| 6 | Wambeke David J. Chief Business Officer |
2024-06-03 17:06:14 | 657,114 0 |
657,114 | Form 4 |
| 7 | Giuffre Randall Michael Director |
2025-02-18 16:25:44 | 392,412 46,643 |
439,055 | Form 4 |
| 8 | Pauls Dietrich John President and CEO |
2024-06-03 16:41:13 | 368,591 0 |
368,591 | Form 4 |
| 9 | Pilnik Richard D. Director |
2025-04-08 16:41:36 | 312,995 0 |
312,995 | Form 4 |
| 10 | Lorianne Masuoka K. Chief Medical Officer |
2024-01-23 16:23:11 | 285,000 0 |
285,000 | Form 4 |
| 11 | Kellen Scott CFO and Secretary |
2024-06-03 16:59:09 | 162,290 0 |
162,290 | Form 4 |
| 12 | Parsons James T. Director |
2025-01-03 16:46:35 | 80,141 0 |
80,141 | Form 4 |
| 13 | Burroughs Amy L. Director |
2023-01-03 16:36:27 | 73,288 0 |
73,288 | Form 4 |
| 14 | Verdoorn Todd A. Chief Scientific Officer |
2019-06-26 16:54:07 | 73,025 0 |
73,025 | Form 4 |
| 15 | Gruis Kirsten L Chief Medical Officer |
2023-06-02 16:55:43 | 67,000 0 |
67,000 | Form 4 |
| 16 | O'Connor Daniel J. Director |
2025-02-24 17:06:33 | 64,242 0 |
64,242 | Form 4 |
| 17 | Daves Julie VanOrsdel SVP Clinical Development Oper. |
2023-06-02 17:16:33 | 54,000 0 |
54,000 | Form 4 |
| 18 | Semba Charles Pauling Director |
2025-01-03 16:15:16 | 44,608 0 |
44,608 | Form 4 |
| 19 | ALCORN HARRY W JR SVP, Clinical Operations |
2021-09-15 16:37:42 | 43,582 399 |
43,981 | Form 4 |
| 20 | Lewis Tanya Director |
2024-06-03 16:14:56 | 28,472 0 |
28,472 | Form 4 |
| 21 | Gilman Sydney A. VP, Regulatory Affairs |
2021-07-29 21:18:27 | 25,000 0 |
25,000 | Form 4 |
| 22 | Kuntz Richard Director |
2025-01-03 16:28:57 | 24,210 0 |
24,210 | Form 4 |
| 23 | Cundari Dominic R Chief Commercial Officer |
2024-06-03 16:58:49 | 17,800 0 |
17,800 | Form 4 |